Five Prime Therapeutics reported $-20852000 in Pre-Tax Profit for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
AstraZeneca AZN:LN 1954M 415M
Bristol Myers Squibb BMY:US $ 5289M 67M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Cytokinetics CYTK:US $ -76.09M 14.53M
Daiichi Sankyo 4568:JP Y 38893M 8169M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Five Prime Therapeutics FPRX:US $ -20.85M 0M
Halozyme Therapeutics HALO:US $ 74.11M 17.41M
Immunogen IMGN:US $ -37.34M 6.6M
IONIS PHARMACEUT IONS:US $ -84M 3M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Macrogenics MGNX:US $ -52.89M 12.95M
Novartis NVS:US $ 4544M 120M
Novartis NOVN:VX SF 4544M 120M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Xencor XNCR:US $ -40.19M 92.44M